These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33677866)

  • 1. [The clinical manifestations and risk factors in primary antiphospholipid syndrome with thrombocytopenia].
    Li S; Lan XL; Cai HC; Zhu TN; Wang SJ; Zhao YQ
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jan; 42(1):33-38. PubMed ID: 33677866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical characteristics of 37 antiphospholipid syndrome patients complicated by autoimmune hemolytic anemia].
    Zhang JT; Qi WT; Zhou YZ; Huang C; Zhao JL; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):147-155. PubMed ID: 36740405
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
    de Azevedo Lopes E; Balbi GGM; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Ji L; Cohen H; de Jesús GR; Branch DW; Nalli C; Petri M; Rodriguez E; Kello N; Ríos-Garcés R; Knight JS; Atsumi T; Willis R; Bertolaccini ML; Erkan D; Andrade D;
    Adv Rheumatol; 2021 Oct; 61(1):64. PubMed ID: 34711275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome.
    da Silva Saraiva S; de Moraes Mazetto B; Quinteiro Tobaldine L; Pereira Colella M; Vinícius De Paula E; Annichinno-Bizzachi J; Andrade Orsi F
    Am J Hematol; 2017 Nov; 92(11):1163-1169. PubMed ID: 28762539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for arterial thrombosis in antiphospholipid syndrome.
    Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
    Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
    Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.
    Appenzeller S; Yeh S; Maruyama M; Barros SM; de Carvalho JF
    Rheumatol Int; 2012 Sep; 32(9):2857-61. PubMed ID: 21881983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
    Pontara E; Banzato A; Bison E; Cattini MG; Baroni G; Denas G; Calligaro A; Marson P; Tison T; Ruffatti A; Pengo V
    J Thromb Haemost; 2018 Mar; 16(3):529-532. PubMed ID: 29316193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analyses of the risk factors for the progression of primary antiphospholipid syndrome to systemic lupus erythematosus].
    Chen SY; Zheng MM; Wang CH; Jiang H; Li J; Zhao JL; Zhao Y; Hou RH; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):170-175. PubMed ID: 38326043
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary Antiphospholipid Syndrome with Livedo Reticularis is Linked to Female Sex and Stroke and Negatively Associated with Thyroid Disease.
    Carvalho JF; de Araujo RPC; Skare TL
    Curr Rheumatol Rev; 2022; 18(4):352-356. PubMed ID: 34784875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and risk factors of microvascular involvement in primary antiphospholipid syndrome: a longitudinal single-center study in China.
    Sun Y; Zhao J; Zhang P; Wu C; Jiang N; Zhou J; Zhang S; Wu Q; Wang Q; Li M; Zeng X
    Lupus; 2019 Nov; 28(13):1558-1565. PubMed ID: 31635555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
    Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
    Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
    Barbati C; Stefanini L; Colasanti T; Cipriano E; Celia A; Gabriele G; Vomero M; Ceccarelli F; Spinelli FR; Finucci A; Speziali M; Orso G; Margiotta DPE; Conti F; Violi F; Afeltra A; Valesini G; Alessandri C
    Arthritis Res Ther; 2019 Jul; 21(1):161. PubMed ID: 31262358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart valve disease in primary antiphospholipid syndrome.
    Niznik S; Rapoport MJ; Avnery O; Kidon M; Shavit R; Ellis MH; Agmon-Levin N
    Rheumatology (Oxford); 2024 May; 63(5):1397-1402. PubMed ID: 37572296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management.
    Radin M; Ugolini-Lopes MR; Sciascia S; Andrade D
    Semin Arthritis Rheum; 2018 Aug; 48(1):117-120. PubMed ID: 29395258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The meaning of non-criteria clinical manifestations in a real-life primary antiphospholipid syndrome cohort.
    Hernández-Molina G; Maldonado-García C; Gamboa-Espíndola M; Cabral AR
    Clin Exp Rheumatol; 2024 May; 42(5):1029-1034. PubMed ID: 38179724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
    Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.